Abstract
Aims: Arrhythmia recurrence is a common clinical problem in patients with pulmonary vein stenosis (PVS) following catheter ablation of atrial fibrillation. The study sought to analyse the management of arrhythmia recurrence in patients with PVS. Methods and results: Retrospective analysis was performed on 29 patients with high-degree PVS. Follow-up contained clinical visits, Holter-electrocardiogram recordings and invasive pulmonary vein (PV) angiography and electrophysiological studies. Arrhythmia recurrence was observed in 18 patients (62%) after PVS formation. Fifteen of 18 patients (83.3%) with and 1 of 11 patients (9.1%) without arrhythmia recurrence had electrical PV reconnection (P = 0.0003). In 14 of 16 patients repeat pulmonary vein isolation (PVI) was conducted (radiofrequency ablation in 12 and cryoballoon ablation in 2 cases). Repeat PVI was successful in all PVs in nine patients and incomplete in five patients (failed attempt in two patients with stent implantation, no attempt in three patients with stenotic PVs). Freedom from arrhythmia recurrence was estimated at 56.3% [95% confidence interval (CI) 36.4-72.0%] after 24 months. At the end of the follow-up, complete PVI was documented in 19 of 23 patients (82.6%) with stable sinus rhythm and in 2 of 6 patients with arrhythmia recurrence (33.3%) (P = 0.0335). The Kaplan-Meier estimate of recurrence-free survival of restenosis after interventional PVS treatment was similar in patients without and with repeat ablation [75.6% (95% CI 57.0-94.3%) and 67.0% (95% CI 43.2-90.7%) after 500 days, P = 0.77]. Conclusions: Pulmonary vein reconnection is the major driver of arrhythmia recurrence in PVS patients. Repeat PVI is feasible and does not lead to progression of PVS or restenosis if the procedure is carefully performed.
| Original language | English |
|---|---|
| Journal | Europace |
| Volume | 21 |
| Issue number | 10 |
| Pages (from-to) | 1494-1501 |
| Number of pages | 8 |
| ISSN | 1099-5129 |
| DOIs | |
| Publication status | Published - 01.10.2019 |
Funding
Conflict of interest: K.-H.K. reports having received consulting fees/honoraria from Biosense Webster, Medtronic, Boston Scientific, and Abbott. A.M. reports having received speaker’s honoraria from Medtronic. R.R.T. reports having received research grants from St. Jude Medical; speaker’s honoraria from Biosense Webster, Biotronik, Pfizer, Topera, Bristol-Myers Squibb, Bayer, and Sanofi Aventis. The other authors report no relevant conflicts of interest.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Management of arrhythmia recurrence in patients with pulmonary vein stenosis following atrial fibrillation ablation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver